Home > Research > Publications & Outputs > Economic impact of musculoskeletal disorders (M...

Research

Links

Text available via DOI:

Keywords

View graph of relations

Economic impact of musculoskeletal disorders (MSDs) on work in Europe

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Economic impact of musculoskeletal disorders (MSDs) on work in Europe. / Bevan, Stephen Mark.
In: Best Practice and Research Clinical Rheumatology, Vol. 29, No. 3, 06.2015, p. 356-373.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Bevan, SM 2015, 'Economic impact of musculoskeletal disorders (MSDs) on work in Europe', Best Practice and Research Clinical Rheumatology, vol. 29, no. 3, pp. 356-373. https://doi.org/10.1016/j.berh.2015.08.002

APA

Bevan, S. M. (2015). Economic impact of musculoskeletal disorders (MSDs) on work in Europe. Best Practice and Research Clinical Rheumatology, 29(3), 356-373. https://doi.org/10.1016/j.berh.2015.08.002

Vancouver

Bevan SM. Economic impact of musculoskeletal disorders (MSDs) on work in Europe. Best Practice and Research Clinical Rheumatology. 2015 Jun;29(3):356-373. doi: 10.1016/j.berh.2015.08.002

Author

Bevan, Stephen Mark. / Economic impact of musculoskeletal disorders (MSDs) on work in Europe. In: Best Practice and Research Clinical Rheumatology. 2015 ; Vol. 29, No. 3. pp. 356-373.

Bibtex

@article{974569997a2d4b09b057f8ea092bd7fb,
title = "Economic impact of musculoskeletal disorders (MSDs) on work in Europe",
abstract = "Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, {\textquoteleft}presenteeism{\textquoteright} and loss of productivity across all the European Union (EU) member states. It is estimated that the total cost of lost productivity attributable to MSDs among people of working age in the EU could be as high as 2% of gross domestic product (GDP). This paper examines the available evidence on the economic burden of MSDs on work across Europe and highlights areas of policy, clinical and employment practice which might improve work outcomes for individuals and families and reduce the economic and social costs of MSDs.",
keywords = "Musculoskeletal, Productivity, Employment, Sickness absence, Work disability, Early intervention, European Union",
author = "Bevan, {Stephen Mark}",
year = "2015",
month = jun,
doi = "10.1016/j.berh.2015.08.002",
language = "English",
volume = "29",
pages = "356--373",
journal = "Best Practice and Research Clinical Rheumatology",
issn = "1521-6942",
publisher = "Bailliere Tindall Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - Economic impact of musculoskeletal disorders (MSDs) on work in Europe

AU - Bevan, Stephen Mark

PY - 2015/6

Y1 - 2015/6

N2 - Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, ‘presenteeism’ and loss of productivity across all the European Union (EU) member states. It is estimated that the total cost of lost productivity attributable to MSDs among people of working age in the EU could be as high as 2% of gross domestic product (GDP). This paper examines the available evidence on the economic burden of MSDs on work across Europe and highlights areas of policy, clinical and employment practice which might improve work outcomes for individuals and families and reduce the economic and social costs of MSDs.

AB - Musculoskeletal disorders (MSDs) are the leading cause of work disability, sickness absence from work, ‘presenteeism’ and loss of productivity across all the European Union (EU) member states. It is estimated that the total cost of lost productivity attributable to MSDs among people of working age in the EU could be as high as 2% of gross domestic product (GDP). This paper examines the available evidence on the economic burden of MSDs on work across Europe and highlights areas of policy, clinical and employment practice which might improve work outcomes for individuals and families and reduce the economic and social costs of MSDs.

KW - Musculoskeletal

KW - Productivity

KW - Employment

KW - Sickness absence

KW - Work disability

KW - Early intervention

KW - European Union

U2 - 10.1016/j.berh.2015.08.002

DO - 10.1016/j.berh.2015.08.002

M3 - Journal article

VL - 29

SP - 356

EP - 373

JO - Best Practice and Research Clinical Rheumatology

JF - Best Practice and Research Clinical Rheumatology

SN - 1521-6942

IS - 3

ER -